SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Noven Pharmaceuticals (NOVN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Todd D. Wiener who wrote (6)8/29/1997
From: John McCarthy   of 66
 
Todd -

Thanks.

I am an investor in Noven and a patient investor in general.

I thought the launch of DentiPatch was pretty horrible. In fact,
management fell over themselves so as - not to talk to - what
DentiPatch sales were for the quarter - even in the 10Q.

An aside:
This is the same management that couldn't stop talking about
a product that they knowingly oversold the year before.

And this, even though they had two of the best Dental Distributors around try to push the product. (Wonder what the promo % fee on this
puppy is going to be)

As such ....

I was wondering if they (mgt.) were still on board with
the product - or were lookin more to RPR to bail them out.
(RPR's bought in at about 500,000 shares I believe.
And I'm sure you are aware that RPR is trying to get an FDA sign-off on a Estrogen/Progestogen Skin Patch. With Noven makin' the drug
delivery stuff.)

Please understand, Noven mgt. DELIBERATELY overshipped their Estrogen patches last year to 'make their numbers.' I can't prove it -
but its sorta obvious. No harm in that - but it distorts the
real SELL-THRU of the product and speaks VOLUMES about the
character of the managment. i.e. LOW RENT - HI FLUFF

It's okay - RPR's mgt. will eventually eat their lunch.

For Dentipatch they brought in 2 seasoned people (I am guessing this is the first time Noven's management has ever managed any type of business - not a knock - just an observation) to help get the product out the door. But they may have brought them in too late - or - the market just doesn't care about the product.

In any event, thanks for your thoughts.

Let's stay in touch and especially watch the sequential sales
growth in DentiPatch.

I am scared .... of dentists.

That's why I thought this product could not miss.

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News